Diabetes

Introduction

Diabetes is one of the most common chronic conditions in the world. It affects how the body turns food into energy, and over time it can affect almost every organ system. The good news is that diabetes is also one of the most studied and best-understood conditions in medicine. Treatments have transformed in the last two decades, and people with diabetes today can live full, long, healthy lives when the condition is well managed.

If you have been told you have diabetes, or prediabetes, or that you may be at risk, this article will help you understand what is happening, what kind of diabetes is being discussed, what the diagnosis means in daily life, what treatments are available, and what to expect over time. Diabetes is not a single disease but a family of conditions with different causes and different paths. Knowing which kind you have shapes everything that follows.

The glucose-insulin cycle showing: ① food broken down into glucose entering the bloodstream, ② pancreatic beta cells releasing insulin, ③ insulin signalling cells to absorb glucose, ④ glucose used for energy or stored, ⑤ blood glucose returning to normal.

*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

To understand diabetes, it helps to understand what happens in the body when blood sugar is working normally.

When you eat, your digestive system breaks down food into glucose, a simple sugar that enters your bloodstream. Your body’s cells need glucose for energy. But glucose cannot enter most cells on its own — it needs a key. That key is insulin, a hormone made by special cells (called beta cells) in your pancreas.

In a healthy system, when blood glucose rises after a meal, the pancreas releases insulin. Insulin signals the cells to absorb glucose from the bloodstream, where it is used for energy or stored for later. Blood glucose then returns to normal.

Diabetes is what happens when this system breaks down. Either the pancreas cannot make enough insulin, or the body’s cells stop responding properly to the insulin that is made, or both. The result is that glucose stays in the bloodstream instead of moving into cells. Blood sugar levels rise, cells go hungry for energy, and over months and years the high blood sugar damages blood vessels, nerves, and organs throughout the body.

This is why diabetes is not just about “sugar.” It is a condition that affects the heart, the kidneys, the eyes, the nerves, the feet, and many other systems because the blood that reaches every organ carries the consequences of unmanaged glucose.

Types of Diabetes

Side-by-side comparison of Type 1, Type 2, and gestational diabetes showing: ① autoimmune beta-cell destruction in Type 1, ② insulin resistance and declining production in Type 2, ③ placental hormones causing insulin resistance in gestational diabetes.

*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

Type 1 diabetes

In Type 1 diabetes, the body’s own immune system attacks and destroys the insulin-producing beta cells in the pancreas. The exact trigger for this autoimmune process is still being studied, but genetic predisposition and likely environmental factors both contribute. The result is that the pancreas eventually makes little or no insulin.

Because insulin is essential for survival, people with Type 1 diabetes must take insulin every day, usually for the rest of their lives. Without insulin, blood glucose rises to dangerous levels within hours to days, and a life-threatening complication called diabetic ketoacidosis (DKA) can develop.

Type 1 diabetes is most often diagnosed in children, teenagers, and young adults, but it can develop at any age. It accounts for roughly 5–10% of all diabetes cases worldwide. It is not caused by diet, weight, or lifestyle choices — this is a frequent misunderstanding that can carry unfair stigma. Type 1 is an autoimmune disease.

Type 2 diabetes

Type 2 diabetes is by far the most common form, accounting for about 90–95% of cases. In Type 2, two things go wrong together: the body’s cells become less responsive to insulin (a state called insulin resistance), and the pancreas gradually struggles to keep up with the increased demand for insulin. Over time, the pancreas may produce less insulin than the body needs.

Type 2 develops gradually, often over many years. It is strongly associated with overweight and obesity, physical inactivity, age, family history, and certain ethnic backgrounds. South Asian populations — including people of Indian origin — have a particularly high risk and tend to develop Type 2 diabetes at lower body weights and younger ages than some other populations. Type 2 used to be called “adult-onset diabetes” but is now increasingly being diagnosed in children and adolescents as childhood obesity has risen.

Unlike Type 1, Type 2 can sometimes be prevented, delayed, or even put into remission in its earlier stages through weight loss, physical activity, and dietary changes. Many people with Type 2 are managed with a combination of lifestyle changes and medications; some eventually need insulin.

Gestational diabetes

Gestational diabetes is a form of high blood glucose that develops during pregnancy in women who did not previously have diabetes. Hormones produced by the placenta during the second half of pregnancy can make the body more resistant to insulin. In most women the pancreas compensates; in some it cannot keep up, and blood glucose rises.

Gestational diabetes usually resolves after the baby is delivered. However, women who have had gestational diabetes have a significantly increased risk of developing Type 2 diabetes later in life, and their children may have a slightly higher long-term risk too. For these reasons, screening during pregnancy is standard care, and follow-up testing after delivery is important.

Other less common types

• Monogenic diabetes (MODY) — caused by a single gene mutation; tends to run strongly in families and is often diagnosed in adolescence or young adulthood. Treatment differs from Type 1 and Type 2 and depends on the specific gene involved.
• Latent Autoimmune Diabetes of Adults (LADA) — sometimes called Type 1.5 diabetes; an autoimmune diabetes that develops more slowly in adults, often initially mistaken for Type 2.
• Secondary diabetes — diabetes caused by another medical condition (such as pancreatic disease or hormonal disorders) or by certain medications (such as long-term steroids).
• Neonatal diabetes — a rare condition diagnosed in the first six months of life, usually due to a genetic mutation.

Prediabetes

Prediabetes is a state in which blood glucose levels are higher than normal but not yet high enough to be diagnosed as diabetes. It is sometimes described as “impaired fasting glucose” or “impaired glucose tolerance,” depending on which test detected it. People with prediabetes are at significantly increased risk of progressing to Type 2 diabetes, often within five to ten years if no changes are made.

Importantly, prediabetes can often be reversed. Major trials have shown that modest weight loss and increased physical activity can substantially reduce the risk of progression to Type 2 diabetes. For this reason, prediabetes is an important diagnosis not because it is itself dangerous in the short term, but because it is a window for action.

Causes and Risk Factors

The causes of diabetes differ by type, and so do the risk factors.

Causes of Type 1 diabetes

Type 1 diabetes is an autoimmune disease. The trigger for the immune attack on beta cells is not fully understood, but the following factors are known or suspected to contribute:

• Genetic predisposition — certain genes (especially in the HLA family) make a person more susceptible. Family history modestly increases risk, although most people who develop Type 1 have no family history.
• Environmental triggers — viral infections, early-life dietary factors, and other environmental influences are thought to play a role, though no single trigger has been confirmed.
• Geography — Type 1 is more common in certain regions, and the reasons are not entirely clear.

Type 1 cannot be prevented based on current scientific understanding. It is not caused by eating sugar, by being overweight, or by lifestyle.

Causes and risk factors for Type 2 diabetes

Type 2 diabetes develops from a combination of genetic predisposition and environmental factors that promote insulin resistance and gradual pancreatic exhaustion. Major risk factors include:

• Overweight and obesity, particularly excess weight around the abdomen
• Physical inactivity
• Age — risk rises after age 45, though Type 2 is now diagnosed in younger people, including adolescents
• Family history of Type 2 diabetes
• Ethnicity — South Asian populations have particularly high rates and tend to develop the condition at lower body weights and younger ages
• History of gestational diabetes in a previous pregnancy
• Polycystic ovary syndrome (PCOS)
• High blood pressure or abnormal cholesterol
• Prediabetes, if it has already been identified
• Sleep disorders such as obstructive sleep apnoea

Many of these risk factors interact. Importantly, several are modifiable — weight, activity, sleep, and diet can be changed.

Causes of gestational diabetes

Gestational diabetes is caused by hormones produced by the placenta that increase insulin resistance during pregnancy, combined with the pancreas’s limited ability to produce enough additional insulin to compensate. Risk factors include older maternal age, higher pre-pregnancy weight, family history of diabetes, prior gestational diabetes, certain ethnic backgrounds, and PCOS.

Signs and Symptoms

The symptoms of diabetes are caused by high blood glucose and by the body’s inability to use glucose for energy. The classic symptoms are:

• Increased thirst — the body tries to flush excess glucose through the urine
• Frequent urination, including at night
• Unexplained weight loss, particularly in Type 1 or in poorly controlled Type 2
• Increased hunger, even after eating
• Fatigue and weakness
• Blurred vision, due to fluid shifts in the lens of the eye
• Slow-healing cuts or sores
• Frequent infections, particularly skin, urinary, or yeast infections
• Tingling, numbness, or pain in the hands or feet
• Darkened skin patches, typically in folds around the neck or armpits (acanthosis nigricans), associated with insulin resistance

Type 1 diabetes often presents quickly, sometimes over days or weeks, with intense symptoms and significant weight loss. It can present as diabetic ketoacidosis (DKA), a medical emergency, particularly in children who have not yet been diagnosed.

Type 2 diabetes often develops silently. Symptoms may be mild or absent for years. Many people are diagnosed during routine blood tests rather than because they noticed symptoms. By the time symptoms appear, complications may already be developing in the background.

Gestational diabetes usually has no symptoms and is detected on routine pregnancy screening.

When to seek medical attention

Persistent symptoms such as constant thirst, frequent urination, unexplained weight loss, or extreme fatigue should be evaluated. If a child or young adult shows these symptoms over a short period and appears unwell, this can be a medical emergency and should be assessed promptly — Type 1 diabetes can become life-threatening if not diagnosed in time.

Diagnosis

Diabetes is diagnosed by measuring blood glucose. The four standard tests are:

• Glycated haemoglobin (HbA1c) — reflects average blood glucose over the previous two to three months. Convenient because no fasting is required. The standard threshold for diagnosing diabetes is HbA1c of 6.5% (48 mmol/mol) or higher; prediabetes is 5.7–6.4% (39–47 mmol/mol).
• Fasting plasma glucose — a blood test after at least 8 hours without food. A fasting glucose of 126 mg/dL (7.0 mmol/L) or higher indicates diabetes; 100–125 mg/dL (5.6–6.9 mmol/L) is prediabetes.
• Oral glucose tolerance test (OGTT) — blood glucose is measured before and 2 hours after drinking a glucose solution. A 2-hour value of 200 mg/dL (11.1 mmol/L) or higher indicates diabetes; 140–199 mg/dL (7.8–11.0 mmol/L) is prediabetes. The OGTT is the standard test for gestational diabetes screening in pregnancy.
• Random plasma glucose — if symptoms are present and a random glucose is 200 mg/dL (11.1 mmol/L) or higher, this confirms diabetes.

For an asymptomatic person, the diagnosis is typically confirmed with a repeat abnormal test on a separate day to avoid false positives.

Distinguishing Type 1 from Type 2

The diagnosis of which type of diabetes a person has is sometimes obvious (a child with classic Type 1 symptoms) and sometimes not (an adult who could have slow-onset Type 1 misclassified as Type 2). Additional tests that help with classification include:

• Autoantibody tests — the presence of GAD, islet cell, IA-2, or zinc transporter 8 antibodies supports Type 1 diabetes.
• C-peptide level — low C-peptide suggests insulin deficiency (Type 1); normal or high suggests insulin resistance with retained insulin production (Type 2).
• Clinical features — age at diagnosis, weight, family history, presence of other autoimmune conditions, and how rapidly the diabetes developed all inform the picture.

Getting the type right matters because treatment differs significantly.

Treatment and Management

Treatment of diabetes is built on four pillars: education, lifestyle (diet, activity, weight), medication, and monitoring. The mix varies by type and by the individual.

Setting glucose targets

For most adults with diabetes, an HbA1c target below 7% (53 mmol/mol) is a commonly used clinical goal, but targets are individualised. Tighter targets (under 6.5%) may be appropriate for some people with shorter duration of diabetes and no significant complications; less stringent targets (under 7.5% or 8%) may be appropriate for older adults, those with limited life expectancy, or those at high risk of hypoglycaemia. The right target is one decided between you and your doctor.

Treatment of Type 1 diabetes

Three insulin delivery methods for Type 1 diabetes: ① multiple daily injections with a pen device, ② continuous subcutaneous insulin pump with cannula, ③ automated insulin delivery system with pump linked to a continuous glucose monitor sensor on the arm.

*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

People with Type 1 diabetes need insulin every day, without exception. Insulin can be delivered by:

• Multiple daily injections (MDI) — combining a long-acting (basal) insulin once or twice a day with short-acting (bolus) insulin before meals.
• Insulin pumps (continuous subcutaneous insulin infusion) — small devices that deliver insulin continuously through a small cannula under the skin, with extra doses given at mealtimes.
• Automated insulin delivery (AID) systems — insulin pumps linked to continuous glucose monitors (CGMs) by an algorithm that automatically adjusts insulin delivery in response to glucose levels. These are sometimes called hybrid closed-loop systems or “artificial pancreas” systems. Current ADA Standards of Care describe AID as the preferred insulin delivery option for people with Type 1 diabetes who can use them safely.

Alongside insulin, the cornerstones of Type 1 management are continuous or self-monitored glucose checking, learning to count carbohydrates to dose mealtime insulin, recognising and treating low blood sugar, and structured diabetes education.

Treatment of Type 2 diabetes

The treatment of Type 2 diabetes typically follows a stepwise approach, starting with lifestyle changes and adding medications as needed. Major classes of medications used in Type 2 diabetes include:

• Metformin — usually considered the initial pharmacologic option for most people with Type 2 diabetes. It reduces glucose production by the liver and modestly improves insulin sensitivity. It does not cause weight gain or hypoglycaemia and has decades of safety data.
• GLP-1 receptor agonists (such as semaglutide, liraglutide, dulaglutide) — injectable (and in some cases oral) medications that increase insulin release after meals, slow gastric emptying, and reduce appetite. They cause weight loss and have shown cardiovascular benefit in clinical trials.
• SGLT-2 inhibitors (such as empagliflozin, dapagliflozin, canagliflozin) — oral medications that cause excess glucose to be excreted in the urine. They have shown significant benefits for the heart and kidneys in clinical trials.
• DPP-4 inhibitors (such as sitagliptin, linagliptin) — oral medications that prolong the action of natural insulin-releasing hormones after meals. Effective but generally have more modest effects than GLP-1 agonists or SGLT-2 inhibitors.
• Sulfonylureas (such as glimepiride, gliclazide) — older oral medications that stimulate the pancreas to release more insulin. Effective but can cause hypoglycaemia and weight gain.
• Thiazolidinediones (pioglitazone) — improve insulin sensitivity. Used less often today because of side-effect profiles.
• Insulin — eventually needed in some people with Type 2 diabetes as pancreatic insulin production declines. Insulin in Type 2 can be added to oral medications.

The choice and combination of medications is increasingly personalised. Current guidelines, including the ADA Standards of Care, emphasise selecting drugs based on individual factors — presence of cardiovascular disease, kidney disease, heart failure, weight goals, and hypoglycaemia risk — not on a one-size-fits-all sequence. GLP-1 agonists and SGLT-2 inhibitors are increasingly chosen early when cardiovascular or kidney protection is a priority.

Treatment of gestational diabetes

Gestational diabetes is initially managed with dietary changes, regular physical activity, and home glucose monitoring. If blood glucose remains above targets, insulin is the most commonly used medication during pregnancy because of its safety profile. Some oral medications (metformin in particular) are used in selected cases. After delivery, blood glucose usually returns to normal, and the medications are stopped, but follow-up testing weeks and years later is important because of the long-term risk of Type 2 diabetes.

Newer therapies and technology

The treatment landscape has changed substantially over the past decade. Continuous glucose monitors are now widely used by people with Type 1 diabetes and increasingly in Type 2, particularly for those on insulin. Automated insulin delivery systems are improving steadily. New medication classes, particularly the GLP-1 receptor agonists, have shown benefits beyond glucose control — including significant weight loss and reduced cardiovascular events. Research continues into immune therapies for Type 1 diabetes, beta-cell transplantation, stem-cell-derived insulin-producing cells, and other approaches that may further change the picture in the coming years.

Lifestyle and Self-Management

Self-management is central to diabetes care. The choices made every day — what to eat, how much to move, how to sleep, how to handle stress — matter as much as medications. None of these substitutes for medical care, but together they shape outcomes profoundly.

Diet

There is no single “diabetes diet.” Major guidelines, including the ADA, emphasise eating patterns that work for the individual rather than rigid prescriptions. Common principles that work across most dietary patterns include:

• Plenty of non-starchy vegetables, whole fruits, legumes, whole grains, nuts and seeds
• Lean protein sources, fish, and reduced consumption of red and processed meat
• Reducing sugar-sweetened beverages and highly processed foods
• Awareness of carbohydrate quantity and quality, particularly for people on insulin
• Portion control and attention to overall calorie balance for those who need to lose weight

Some people do well on a Mediterranean-style diet; others on a lower-carbohydrate approach; others on culturally appropriate dietary patterns adapted for diabetes. A dietitian or diabetes educator can help build an eating plan that fits the individual’s preferences, culture, and medical situation.

Physical activity

Regular physical activity improves insulin sensitivity, helps with weight management, lowers blood glucose, and benefits cardiovascular health. Major guidelines suggest at least 150 minutes per week of moderate-intensity aerobic activity for adults with diabetes, plus muscle-strengthening activity on two or more days per week. For children and adolescents, the recommendation is 60 minutes of moderate-to-vigorous activity most days. Even modest increases in daily movement — walking, taking stairs, gardening — have measurable benefit.

For people on insulin or some other glucose-lowering medications, exercise can cause hypoglycaemia, and adjustments may be needed before, during, and after activity. This is a topic to discuss with the diabetes team.

Weight management

For people with Type 2 diabetes and overweight or obesity, weight loss has substantial benefits — modest reductions (5–10% of body weight) can meaningfully improve glucose control, blood pressure, and lipids. Larger weight loss (15% or more) can lead to remission of Type 2 diabetes in some people, particularly when achieved early after diagnosis. Approaches to weight loss include dietary change, increased activity, structured programs, certain medications, and in some cases bariatric surgery. For Type 1 diabetes, weight is also clinically relevant but the framing is different — insulin can promote weight gain, and balanced strategies are needed.

Sleep and stress

Poor sleep and chronic stress affect glucose control through hormonal pathways. Obstructive sleep apnoea is particularly common in people with Type 2 diabetes and worth screening for. Managing stress, mental health, and sleep is part of diabetes care.

Smoking and alcohol

Smoking accelerates the cardiovascular and microvascular complications of diabetes and is strongly discouraged in any patient with diabetes. Alcohol can affect blood glucose unpredictably, particularly in people on insulin or sulfonylureas, and can mask hypoglycaemia. Moderation and discussion with the diabetes team are sensible.

Monitoring and Targets

Diabetes is monitored through several different measurements over different time scales.

HbA1c

This blood test, performed in a laboratory, reflects average blood glucose over the previous two to three months. For most adults with diabetes it is checked every three to six months. It is the single most-used measure of long-term glucose control and the basis on which most clinical decisions about medication adjustment are made.

Self-monitored blood glucose

Finger-prick blood glucose testing remains an important tool, particularly for people on insulin. Frequency varies — multiple times daily for those on intensive insulin regimens, less often for those on oral medications.

Continuous glucose monitoring (CGM)

CGM devices use a small sensor placed under the skin to measure glucose every few minutes, with data sent to a phone or receiver. CGM provides far richer information than finger-prick testing — trends, patterns, time in target range, and alerts for highs and lows. Current ADA Standards of Care recommend CGM at diagnosis (and any time after) for children, adolescents, and adults with diabetes who are on insulin therapy or on other therapies that can cause low blood sugar.

Continuous glucose monitor showing: ① small filament sensor inserted just under the skin surface, ② adhesive patch holding the transmitter on the arm, ③ wireless signal transmitting glucose readings to a smartphone receiver.

*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

Other regular tests

Diabetes care includes regular monitoring of related health measures:

• Blood pressure — checked at every visit. Many adults with diabetes have a blood pressure goal below 130/80 mmHg; for those at high cardiovascular or kidney risk, recent guidelines suggest a systolic goal below 120 mmHg if it can be achieved safely.
• Cholesterol and lipid profile — checked periodically. Statin therapy is commonly used to reduce cardiovascular risk in adults with diabetes.
• Kidney function — eGFR (a blood test) and urine albumin (urine test) are checked at least annually.
• Eye examination — a dilated eye exam by an eye specialist, at least annually for most people with diabetes, to detect diabetic retinopathy.
• Foot examination — an annual foot exam, looking for loss of sensation, circulation problems, and skin breakdown.
• Dental check-up — gum disease is more common and harder to treat in people with diabetes.

Complications

The complications of diabetes are the reason the condition is taken so seriously. Most are caused by years of higher-than-normal blood glucose damaging blood vessels and nerves. Many can be slowed, prevented, or detected early with consistent care.

Acute complications

• Hypoglycaemia (low blood sugar) — the most common acute problem, particularly for people on insulin or sulfonylureas. Mild hypoglycaemia causes shakiness, sweating, hunger, irritability, and confusion. Severe hypoglycaemia can cause loss of consciousness or seizures and is a medical emergency. Carrying a fast-acting carbohydrate source, recognising early signs, and knowing how to treat it are core diabetes skills.
• Diabetic ketoacidosis (DKA) — a life-threatening condition that develops when severe insulin deficiency causes the body to break down fat for energy, producing acidic ketones. It is most common in Type 1 diabetes, particularly at first diagnosis or during illness. Symptoms include severe thirst, frequent urination, nausea, vomiting, abdominal pain, deep rapid breathing, and confusion. DKA requires urgent hospital treatment.
• Hyperosmolar hyperglycaemic state (HHS) — a serious complication seen more often in Type 2 diabetes, with very high blood glucose and severe dehydration but without significant ketones. Requires urgent hospital care.

Long-term microvascular complications (small blood vessels)

Major microvascular and macrovascular complications of diabetes affecting: ① retina of the eye (retinopathy), ② kidneys (nephropathy), ③ peripheral nerves in the feet (neuropathy), ④ coronary arteries of the heart, ⑤ peripheral arteries of the legs.

*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.

• Diabetic retinopathy — damage to the blood vessels of the retina. Can progress to vision loss if untreated. Detected by annual eye exams; treated with laser therapy, intraocular injections, or surgery depending on stage.
• Diabetic nephropathy (kidney disease) — gradual loss of kidney function. Detected early by urine albumin and blood eGFR tests. Treatment focuses on blood pressure and glucose control, certain medications (ACE inhibitors, ARBs, SGLT-2 inhibitors, finerenone), and management of risk factors. Advanced kidney disease may eventually require dialysis or kidney transplantation.
• Diabetic neuropathy (nerve damage) — can affect peripheral nerves (causing pain, tingling, numbness, particularly in the feet), autonomic nerves (affecting digestion, blood pressure regulation, bladder, and sexual function), or specific nerves. Foot neuropathy is particularly important because loss of sensation can lead to unnoticed injuries.

Long-term macrovascular complications (large blood vessels)

• Coronary artery disease — people with diabetes have a significantly higher risk of heart attack and heart failure than the general population.
• Stroke — cerebrovascular risk is also higher.
• Peripheral arterial disease — reduced blood flow to the legs and feet, contributing to leg pain on walking and to slow-healing wounds.

Foot complications

The combination of neuropathy, poor circulation, and infection risk makes the diabetic foot a major area of attention. Small injuries that would heal easily in others can progress to non-healing ulcers, infections, and in severe cases to amputation. Daily foot checks, well-fitted footwear, regular podiatry care, and prompt attention to any wound are central to prevention.

Mental health

Depression, anxiety, and diabetes distress (the emotional burden of managing the condition daily) are significantly more common in people with diabetes than in the general population. Mental health affects glucose management, and unmanaged diabetes can worsen mental health — the two systems are linked. Mental health is part of comprehensive diabetes care.

Other complications

• Increased susceptibility to infections, particularly skin, urinary, and yeast infections
• Gum disease and tooth loss
• Sexual dysfunction in both men and women
• Sleep disturbances and obstructive sleep apnoea
• Skin conditions
• Hearing impairment, increasingly recognised as more common in diabetes

Living with Diabetes

Diabetes is a condition you carry through your daily life. The medical management is real, but so is the lived experience — the constant attention to what you eat, how you feel, whether your numbers are in range. People learn to integrate it. The condition becomes part of life rather than the whole of life. Below are some areas where day-to-day reality is often discussed.

Daily routine

For Type 1 diabetes, daily routine includes monitoring glucose, calculating carbohydrates at meals, dosing insulin, watching for highs and lows, and adjusting in response to exercise, illness, and stress. For Type 2 diabetes, the daily routine may be lighter (or heavier, depending on the regimen) — medications, food choices, activity, and monitoring. Routine helps. Burnout is real and worth talking about with the diabetes team if it sets in.

Work and travel

Most jobs are compatible with diabetes, though some safety-critical roles (commercial pilot, certain transport roles) have specific medical fitness requirements that vary by country. Travel requires planning — carrying medications, insulin, and supplies in carry-on luggage; planning across time zones; carrying medical letters. Time-zone shifts can affect insulin scheduling for Type 1.

Driving

People on insulin or sulfonylureas need to take care to avoid hypoglycaemia while driving — checking glucose before driving, having fast-acting sugar accessible, and not driving when low. Different countries have different licensing rules regarding diabetes; checking local requirements matters.

Pregnancy planning

For women of reproductive age with pre-existing diabetes (Type 1 or Type 2), pregnancy is best planned with optimal glucose control in place before conception. High blood glucose in early pregnancy increases the risk of congenital abnormalities. Preconception care typically includes optimising HbA1c, reviewing medications (some diabetes medications are not used in pregnancy), screening for diabetic complications, and folic acid supplementation. Pregnancy in women with diabetes is usually managed by a specialist team.

Emotional and family support

Diabetes affects relationships. Partners, parents, and children often share the load. Diabetes distress and burnout deserve attention, and structured support — from diabetes educators, peer groups, or mental health professionals — can make a real difference.

Diabetes in Children and Adolescents

Diabetes in children deserves its own consideration because the medical, developmental, and family aspects differ from adult diabetes.

Type 1 diabetes in children

Type 1 is the most common form of diabetes in children and teenagers, though it can occur at any age. The peak ages at diagnosis are around 4–6 years and again around 10–14 years. Children with Type 1 diabetes need insulin from the time of diagnosis, lifelong.

Current guidelines, including the ADA Standards of Care, recommend continuous glucose monitoring from the time of diagnosis for children with Type 1 diabetes. Automated insulin delivery (AID) systems are described in current ADA guidelines as the preferred insulin delivery method for children with Type 1 diabetes who can use them safely. These technologies have substantially improved glucose control and quality of life for many children, though they are not yet universally available.

Key aspects of paediatric Type 1 care include:

• Family-centred education — parents and caregivers, and increasingly the child themselves as they grow, learn carbohydrate counting, insulin dosing, glucose monitoring, and how to handle illness, exercise, and special days.
• School support — written diabetes management plans for school, training for school staff, and arrangements for monitoring, insulin doses, snacks, and exercise during the school day.
• Growth and development — regular monitoring of height, weight, and puberty.
• Transition to adulthood — structured transition from paediatric to adult diabetes care, usually in the late teens.
• Mental health — depression, anxiety, and disordered eating are more common in adolescents with diabetes than in their peers and merit attention.

Type 2 diabetes in children

Type 2 diabetes was once almost unheard of in children, but is now diagnosed in adolescents, particularly those with obesity, family history, and from higher-risk ethnic backgrounds. It tends to be more aggressive in children than in adults, with faster progression of complications, and is often harder to treat. Lifestyle changes are central, and metformin is commonly used as initial pharmacologic treatment; insulin and GLP-1 receptor agonists are used when needed. Specialist paediatric endocrinology care is important.

Other paediatric considerations

Maturity-onset diabetes of the young (MODY), neonatal diabetes, and diabetes secondary to other conditions (such as cystic fibrosis-related diabetes) can also present in childhood and require specific approaches. A paediatric endocrinologist is usually best placed to differentiate and manage these.

Prevention

Whether diabetes can be prevented depends on the type. Type 1 diabetes cannot be prevented based on current knowledge; research into immune-modulating therapies to delay onset in high-risk individuals is ongoing. Type 2 diabetes, in contrast, can often be prevented or delayed.

Preventing Type 2 diabetes

For people with prediabetes or other risk factors, large clinical trials have shown that the risk of progression to Type 2 diabetes can be significantly reduced through:

• Weight loss of 5–7% of body weight, sustained
• Increased physical activity — about 150 minutes per week of moderate activity
• Improved diet quality — the patterns described in the lifestyle section
• In some cases, metformin — particularly in younger adults with strong risk factors and significant obesity, this is sometimes discussed with the doctor as a preventive option, although lifestyle measures come first

Structured diabetes prevention programmes — small-group lifestyle interventions delivered over months — have a substantial track record of preventing or delaying Type 2 diabetes when participants engage consistently.

Preventing complications in established diabetes

For someone who already has diabetes, “prevention” means preventing or delaying complications. This is built on:

• Consistent glucose control toward individualised targets
• Blood pressure and lipid management
• Regular screening for complications — eyes, kidneys, feet, heart
• Not smoking
• Vaccinations as recommended (influenza, pneumococcal, others as relevant)
• Mental health care
• Adherence to follow-up and medication

The evidence that good glucose control reduces complications is among the strongest in medicine. The work is real, but the results are real too.

When to Seek Urgent Care

Most diabetes care is planned and routine. But there are situations where urgent or emergency medical care is needed:

• Severe hypoglycaemia — unable to treat yourself, loss of consciousness, or seizure
• Persistent vomiting, especially if you cannot keep fluids down
• Signs of diabetic ketoacidosis — deep rapid breathing, abdominal pain, breath with a fruity smell, confusion, very high blood glucose with ketones
• Very high blood glucose (above 300 mg/dL or 16.7 mmol/L) with symptoms
• Severe dehydration or confusion
• Chest pain, shortness of breath, or signs of a heart attack or stroke
• A foot wound that is rapidly worsening, red, hot, or with pus
• Sudden vision changes

People with diabetes — particularly Type 1 — benefit from having a written “sick day” plan from their diabetes team that explains how to adjust insulin, monitoring, and fluids during illness.

Frequently Asked Questions

Can diabetes be cured?

Type 1 diabetes cannot currently be cured. Lifelong insulin replacement is the standard of care, and research into restoring beta-cell function continues. Type 2 diabetes is generally a chronic condition, but in some people, particularly soon after diagnosis, it can go into remission — meaning HbA1c stays in the normal range without diabetes medication — especially after significant weight loss or bariatric surgery. Remission is not the same as cure; the underlying tendency remains and the diabetes can return.

Is diabetes hereditary?

Both Type 1 and Type 2 diabetes have genetic components, but neither is purely inherited. Type 2 has a stronger family pattern in most populations. Having a parent or sibling with diabetes increases your risk but does not make diabetes certain, and many people develop diabetes with no known family history. Lifestyle and environmental factors interact with genetics, particularly in Type 2.

Can I eat sugar if I have diabetes?

Foods containing sugar are not forbidden in diabetes, but quantity and context matter. For someone on insulin, the carbohydrate in any food — sugary or starchy — needs to be counted to dose insulin correctly. For everyone with diabetes, frequent sugar-sweetened drinks and large amounts of refined sugar make glucose harder to control. The simple framing “no sugar ever” is outdated; the more accurate framing is balanced eating with awareness of carbohydrates.

Will I have to take insulin?

Type 1 diabetes always requires insulin. Type 2 diabetes may or may not require insulin — some people manage with lifestyle changes alone, many take oral or non-insulin injectable medications, and some eventually need insulin as the pancreas’s ability to make insulin declines. Starting insulin in Type 2 is not a failure; it is a step in matching treatment to the body’s changing needs.

Can I drink alcohol with diabetes?

Alcohol is generally acceptable in moderation for most adults with diabetes, but it can affect blood glucose unpredictably, lower glucose hours after drinking (particularly with insulin or sulfonylureas), and mask the symptoms of hypoglycaemia. Eating with alcohol, monitoring glucose more carefully, and discussing limits with the diabetes team are all sensible.

Can I exercise normally with diabetes?

Yes — in fact, exercise is part of good diabetes care. People on insulin or sulfonylureas need to be aware of and prepared for low blood glucose during or after exercise. For people without these medications, the main considerations are general fitness and any complications (cardiovascular, eye, foot) that may require modifications.

How often will I need to see a doctor?

Most adults with stable diabetes see a doctor every three to six months for HbA1c, medication review, and general assessment. Initial follow-up after a new diagnosis or when therapy is being adjusted is more frequent. Annual or longer-interval reviews for eyes, feet, kidneys, and other systems are also part of care.

What is HbA1c and what should mine be?

HbA1c (sometimes written A1C) is a blood test that reflects your average blood glucose over the previous two to three months. It is expressed as a percentage (or as mmol/mol in some countries). A common target for adults with diabetes is below 7% (53 mmol/mol), but the right target depends on age, health, life expectancy, and risk of low blood sugar — and is individualised with your doctor.

If I have prediabetes, will I definitely get Type 2?

No. Many people with prediabetes go on to develop Type 2 diabetes if no changes are made, but prediabetes is reversible. Sustained weight loss, increased physical activity, and dietary improvements can substantially reduce or delay progression, in some cases bringing blood glucose back to the normal range.

Is gestational diabetes dangerous for my baby?

Gestational diabetes that is not well controlled can affect the baby — through excessive growth, low blood glucose at birth, breathing difficulties, and higher rates of later metabolic problems. With good monitoring and treatment, the risks are substantially reduced. Most women with gestational diabetes have healthy babies.

Conclusion

Diabetes is a family of related conditions sharing the feature of high blood glucose. The right approach depends on which type a person has, on individual circumstances, and on goals worked out with the medical team. The science is rich, the treatments are powerful, and the daily reality is one of ongoing self-management supported by good medical care.

Living well with diabetes is possible. The condition rewards consistency — in monitoring, in medication, in lifestyle, in follow-up — and modern care provides more tools than ever to make that consistency easier. Whether the question is what type of diabetes is present, what treatment fits best, or how to handle a particular complication, those answers are best worked out with a healthcare team that knows the individual.